We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$247M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$183M |
| 3 |
WCC
WESCO International
WCC
|
+$178M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
Delta Air Lines
DAL
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$157M |
| 3 |
MRSH
Marsh
MRSH
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$106M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRX
526
Marex Group Limited Ordinary Shares
MRX
$4.53B
| $14M | 0.02% |
450,274
-83,018
| -16% | -$2.32M |
|
527
Capital One
COF
$136B
| $14M | 0.02% |
78,522
-28,683
| -27% | -$4.97M |
|
528
Cheniere Energy
LNG
$55.4B
| $14M | 0.02% |
65,000
-100,000
| -61% | -$20.3M |
|
529
VeriSign
VRSN
$26.5B
| $13.9M | 0.02% |
67,240
-6,900
| -9% | -$1.3M |
|
530
M&T Bank
MTB
$36.3B
| $13.9M | 0.02% |
74,007
+39,917
| +117% | +$7.93M |
|
531
PTC Therapeutics
PTCT
$5.85B
| $13.8M | 0.02% |
306,756
+56,756
| +23% | +$2.43M |
|
|
SGI
532
Somnigroup International
SGI
$13.8B
| $13.7M | 0.02% |
242,233
-307,767
| -56% | -$16.4M |
|
533
Align Technology
ALGN
$12.3B
| $13.7M | 0.02% |
65,600
-51,002
| -44% | -$11.4M |
|
534
Ryman Hospitality Properties
RHP
$7.86B
| $13.6M | 0.02% |
130,000
-95,000
| -42% | -$10.6M |
|
535
RadNet
RDNT
$5.29B
| $13.6M | 0.02% |
194,157
-89,171
| -31% | -$6.58M |
|
536
Molina Healthcare
MOH
$10B
| $13.5M | 0.02% |
46,400
-3,800
| -8% | -$1.17M |
|
|
DYNCU
537
Dynamix Corp Unit
DYNCU
| $13.4M | 0.02% |
+1,350,000
| New | +$13.4M |
|
538
Aptiv
APTV
$9.72B
| $13.3M | 0.02% |
219,600
-252,900
| -54% | -$15.5M |
|
539
Healthpeak Properties
DOC
$14.7B
| $13.2M | 0.02% |
653,443
-9,900
| -1% | -$215K |
|
540
Landstar System
LSTR
$6.05B
| $13.2M | 0.02% |
+77,000
| New | +$14.1M |
|
541
Evergy
EVRG
$19.1B
| $13.2M | 0.02% |
214,882
-1,900
| -0.9% | -$117K |
|
542
Monopar Therapeutics
MNPR
$818M
| $13.2M | 0.02% |
+599,195
| New | +$10.1M |
|
|
TLN
543
Talen Energy Corp
TLN
$16.4B
| $13.1M | 0.02% |
65,000
-55,000
| -46% | -$10.7M |
|
544
Heron Therapeutics
HRTX
$94.5M
| $13M | 0.02% |
8,500,000
-350,000
| -4% | -$567K |
|
545
Aligos Therapeutics
ALGS
$32.1M
| $12.9M | 0.02% |
325,000
+106,187
| +49% | +$2.05M |
|
546
JB Hunt Transport Services
JBHT
$25.4B
| $12.7M | 0.02% |
74,400
-96,500
| -56% | -$17.2M |
|
547
Safety Insurance
SAFT
$1.52B
| $12.6M | 0.02% |
153,000
-7,000
| -4% | -$580K |
|
548
Cullinan Oncology
CGEM
$1.05B
| $12.6M | 0.02% |
1,030,438
-325,438
| -24% | -$4.68M |
|
549
Brixmor Property Group
BRX
$9.37B
| $12.5M | 0.02% |
450,000
-315,000
| -41% | -$8.93M |
|
550
Tyson Foods
TSN
$20.6B
| $12.4M | 0.02% |
216,055
-53,400
| -20% | -$3.23M |
|
Similar funds
Adage Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
- Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
- Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
- Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
- Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
- Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
- Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.
Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.